Latest News about TAK
Recent news which mentions TAK
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
February 04, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut
January 29, 2020
From Benzinga
Biotech's Most Volatile Binary Events for Q1
January 03, 2020
From Motley Fool
Here's Why Mirum Pharmaceuticals' Stock Jumped in December
January 02, 2020
From Motley Fool
A $20 Billion Sweet Spot in Biotech
December 28, 2019
From Motley Fool
Will Karyopharm’s Stock Take Off in 2020?
December 20, 2019
From Motley Fool
4 Healthcare Services Companies to Own for the Future
December 19, 2019
From Motley Fool
1 Attractive Pharma Stock You Probably Haven't Heard Of
November 21, 2019
From Motley Fool
2 Biotech Stocks Fighting Alzheimer’s Disease to Own Now
November 09, 2019
From Motley Fool
3 Dividend Stocks That Pay Better Than Coca-Cola
November 07, 2019
From Motley Fool
10 Healthcare Stocks Moving In Tuesday's Pre-Market Session
November 05, 2019
From Benzinga
The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment
November 05, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For Npvember 1, 2019
November 01, 2019
From Benzinga
The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug
October 22, 2019
From Benzinga
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
October 15, 2019
From Benzinga
Big Pharma Has Mad Love For These 2 Biotechs
October 11, 2019
From Motley Fool
From Benzinga
21 Healthcare Stocks Moving In Friday's Pre-Market Session
September 27, 2019
From Benzinga
The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
September 26, 2019
From Benzinga
The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger
September 24, 2019
From Benzinga
The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication
September 06, 2019
From Benzinga
From MarketWatch
Five stocks trading at under $10 worth discovering
June 27, 2019
From MarketWatch
Amgen, Biogen, Gilead and Novo Nordisk have ‘very high’ capacity for M&A, says Moody’s
June 13, 2019
From MarketWatch
From Benzinga
BioCryst Trades Sharply Lower Despite Acing Late-Stage Hereditary Angioedema Drug Trial
May 21, 2019
From Benzinga
58 Biggest Movers From Yesterday
May 15, 2019
From Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
May 14, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.